Multiple organ dysfunction syndrome in humans and dogs

Journal of Veterinary Emergency and Critical Care

Volumn 14, Issue 3, 2004, Pages 158-166

  Johnson, Valerie ^a,c   Gaynor, Alison ^b   Chan, Daniel L ^b   Rozanski, Elizabeth ^b,d  

^a Animal Emergency Center   (United States)

^b TUFTS UNIVERSITY   (United States)

^c AEC   (United States)

^d TUFTS UNIVERSITY   (United States)

Author keywords

ARDS; Canine; MODS; Multiple organ failure; Sepsis; SIRS

Indexed keywords

ACTIVATED PROTEIN C; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; DOBUTAMINE; DOPAMINE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; NORADRENALIN;

ACUTE KIDNEY FAILURE; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DOG; FLUID THERAPY; GASTROINTESTINAL DISEASE; HEART OUTPUT; HEMATOLOGIC DISEASE; HUMAN; ISCHEMIA; KIDNEY DISEASE; LIVER DYSFUNCTION; MEDICAL PRACTICE; MULTIPLE ORGAN FAILURE; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; REPERFUSION INJURY; RESPIRATORY FAILURE; REVIEW; SCORING SYSTEM; SEPSIS; VENTILATOR; VETERINARY MEDICINE;

CANIS FAMILIARIS;

EID: 13444287725     PISSN: 14793261     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1534-6935.2004.04016.x     Document Type: Review

References (81)

1. Fry DE. Sepsis syndrome. Am Surg 2000; 66:26-132.
2. Balk RA. Severe sepsis and septic shock. Crit Care Clin 2000; 16(2):179-92.
3. Seely AJ, Christou NV. Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 2000; 28(7):2193-2200.
4. Hardie EM. Life threatening bacterial infection. Compend Cont Ed Pract Vet 1995; 17(6):763-77.
5. Hauptman JG, Walshaw R, Olivier NB. Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs. Vet Surg 1997; 26:393-7.
6. Bone RC, Balk RA, Cerra FB, et al. ACCP/SCCM Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20(6):864-74.
7. Balk RA. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin 2000; 16(2):337-352.
8. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003; 348:727-734.
9. Dietch EA, Goodman ER. Prevention of multiple organ failure. Surg Clin North Am 1999; 79(6):471-488.
10. Bota DP, Melot C, Ferreira FL, et al. The multiple organ dysfunction score (MODS) versus the sequential organ failure assessment (SOFA) score in outcome prediction. Intens Care Med 2002; 28:1619-1624.
11. Pettila V, Pettila M, Sarna S, et al. Comparison of multiple organ dysfunction scores in the prediction of hospital mortality in the critically ill. Crit Care Med 2002; 30(8):1705-1711.
12. Papathanassoglou EDE, Moynihan JA, Ackerman MH. Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and theoretical framework. Crit Care Med 2000; 28(2):537-549.
13. Kim PK, Deutschman CS. Inflammatory responses and mediators. Surg Clin North Am 2000; 80(3):885-894.
14. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997; 112(1):235-243.
15. Vincent JL. Update on sepsis: pathophysiology and treatment. Acta Clinica Belgica 2000; 55(2):70-87.
16. Karima R, Matsumoto S, Higashi H, et al. The molecular pathogenesis of endotoxic shock and organ failure. Molec Med Today 1999; 5(3):123-129.
17. Aldridge AJ. Role of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur J Surg 2002; 168(4):204-214.
18. Price SA, Spain DA, Wilson MA, et al. Altered vasoconstrictor and dilator responses after a "two-hit" model of sequential hemorrhage and bacteremia. J Surg Res 1999; 81:59-64.
19. Garrison RN, Spain DA, Wilson MA, et al. Microvascular changes explain the "two-hit" theory of multiple organ failure. Ann Surg 1998; 227:851-860.
20. Maier RV. Pathogenesis of multiple organ dysfunction syndrome-endotoxin, inflammatory cells, and their mediators: cytokines and reactive oxygen species. Surg Infect 2000; 1:197-205.
21. Opal SM, Gluck T. Endotoxin as a drug target. Crit Care Med 2003; 31:S57-S64.
22. Flanagan PG, Barnes RA. Fungal infections in ICU. J Hosp Infect 1999; 41:337-339.
23. Opal SM, Cohen J. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit Care Med 1999; 27:1608-1616.
24. Mizock BA. Metabolic derangements in sepsis and septic shock. Crit Care Clin 2000; 16(2):319-336.
25. Druml W, Heinzel G, Kleinberger G. Amino acid kinetics in patients with sepsis. Am J Clin Nutr 2001; 73:908-913.
26. Novak F, Heyland DK, Avenell A, et al. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002; 30(9):2022-2029.
27. Goeters C, Wenn A, Mertes N, et al. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patienst. Crit Care Med 2002; 30(9):2032-2037.
28. Karner J, Roth E, Ollenschlager G, et al. Glutamine-containing dipeptides as infusion substrates in the septic state. Surg 1989; 106(5):893-900.
29. Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 2001; 94(6):1133-1138.
30. Bateman SW, Mathews KA, Abrams-Ogg AC. Disseminated intravascular coagulation in dogs: review of the literature. J Vet Emerg Crit Care 1998; 8(1):29-45.
31. Bulger EM, Maier RV. Antioxidants in critical illness. Arch Surg 2001; 136(10):1201-1207.
32. Alonso de Vega JM, Diaz J, Serrano E, et al. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 2002; 30(8):1782-1786.
33. Suter PM, Domenighetti G, Schaller MD, et al. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest 1994; 105(1):109-114.
34. Barquist E, Kirton O, Windsor J, et al. The impact of antioxidant and splanchnic-directed therapy on persistent uncorrected gastric mucosal pH in the critically injured trauma patient. J Trauma 1998; 44(2):355-360.
35. Angstwurm MW, Schottdorf J, Schopohl J, et al. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 1999; 27(9):1807-1813.
36. Paterson RL, Galley HF, Webster NR. The effects of N-acetylcysteine on nuclear factor-kB activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med 2003; 31(11):2574-2578.
37. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 1996; 24(1):163-172.
38. Fisher CJ, Agosti JM, Opal SM, et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The soluble TNF receptor sepsis study group. N Engl J Med 1996; 334(26):1697-1702.
39. Abraham E, Wunderink R, Silverman H, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial TNF-alpha MAb Sepsis Study Group. J Am Med Assoc 1995; 273(12):934-941.
40. Bernard GR, Artigas A, Brigham KL, et al. Consensus Committee. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824.
41. Fein AM, Calalang-Colucci MG. Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock. Crit Care Clin 2000; 16(2):289-317.
42. Lee WL, Detsky AS, Stewart TE. Lung-protective mechanical ventilation strategies in ARDS. Int Care Med 2000; 26:1151-1155.
43. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342(18):1301-1308.
44. Pellett AA, Lord KC, Champagne MS, et al. Pulmonary capillary pressure during acute lung injury in dogs. Crit Care Med 2002; 30(2):403-409.
45. Koshida T, Ishizaka A, Nagatomi I, et al. Pretreatment with FK506 improves survival rate and gas exchange in canine model of acute lung injury. Am J Respir Crit Care Med 2001; 163(1):79-84.
46. Blanch L, Van der Kloot TE, Youngblood AM, et al. Application of tracheal gas insufflation to acute unilateral lung injury in an experimental model. Am J Respir Crit Care Med 2001; 164(4):642-647.
47. Parent C, King LG, Walker LM, et al. Clinical and clinicopathologic findings in dogs with acute respiratory distress syndrome: 19 cases (1985-1993). J Am Vet Med Assoc 1996; 208(9):1419-1427.
48. Parent C, King LG, Van Winkle TJ, et al. Respiratory function and treatment in dogs with acute respiratory distress syndrome: 19 cases (1985-1993). J Am Vet Med Assoc 1996; 208(9):1428-1433.
49. Drellich S. Principles of mechanical ventilation. Vet Clin North Am Small Anim Pract 2002; 32(5):1087-1100.
50. Kumar A, Haery C, Parrillo JE. Myocardial dysfunction in septic shock. Crit Care Clin 2000; 16(2):251-287.
51. Purvis D, Kirby R. Systemic inflammatory response syndrome: septic shock. Vet Clin North Am Small Anim Pract 1994; 24(6):1225-1247.
52. Hardie EM. Therapeutic management of sepsis, In: Bonagura JD. eds. Kirk's Current Veterinary Therapy XIII. Philadelphia: WB Saunders Co.; 2000, pp. 272-275.
53. Miller TL, Schwartz DS, Nakayama T, et al. Effects of acute gastric distension and recovery on tendency for ventricular arrhythmia in dogs. J Vet Intern Med 2000; 14(4):436-444.
54. Snyder PS, Cooke KL, Murphy ST, et al. Electrocardiographic findings in dogs with motor vehicle-related trauma. J Am Anim Hosp Assoc 2001; 37(1):55-63.
55. Cheng ZQ, Bose D, Jacobs H, et al. Sepsis causes presynaptic histamine H3 and alpha2-adrenergic dysfunction in canine myocardium. Cardiovasc Res 2002; 56(2):225-234.
56. Jha P, Jacobs H, Bose D, et al. Effects of E. coli sepsis and myocardial depressant factor on interval-force relations in dog ventricle. Am J Physiol 1993; 264(5 Pt 2):H1402-H1410.
57. Abernethy VE, Lieberthal W. Acute renal failure in the critically ill patient. Crit Care Clin 2002; 18(2):203-222.
58. Zager RA. Sepsis-associated acute renal failure: some potential pathogenetic and therapeutic insights. Nephrol Dial Transplant 1994; 9(Suppl. 4):164-167.
59. Behrend EN, Grauer GF, Mani I, et al. Hospital-acquired acute renal failure in dogs: 29 cases (1983-1992). J Am Vet Med Assoc 1996; 208(4):537-541.
60. Vaden SL, Levine J, Breitschwerdt EB. A retrospective case-control of acute renal failure in 99 dogs. J Vet Intern Med 1997; 11(2):58-64.
61. King L. Postoperative complications and prognostic indicators in dogs and cats with septic peritonitis: 23 cases (1989-1992). J Am Vet Med Assoc 1994; 204(3):407-414.
62. Bateman SW, Mathews KA, Abrams-Ogg AC, et al. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit. J Am Vet Med Assoc 1999; 215(6):798-804.
63. Weiss DJ, Rashid J. The sepsis-coagulant axis: a review. J Vet Intern Med 1998; 12:317-324.
64. Dries DJ. Activation of the clotting system and complement after trauma. New Horizons 1996; 4(2):276-288.
65. Hack CE. Tissue factor pathway of coagulation in sepsis. Crit Care Med 2000; 28(9 Suppl.):S25-S30.
66. Aird WC. Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis. Crit Care Med 2001; 29(7 Suppl.):S28-S35.
67. Cicala C, Cirino G. Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk. Life Sci 1998; 62(20):1817-1824.
68. Vallet B, Wiel E. Endothelial cell dysfunction and coagulation. Crit Care Med 2001; 29(7 Suppl.):S36-S41.
69. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344(10):699-709.
70. de Laforcade AM, Freeman LM, Shaw SP, et al. Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med 2003; 17(5):674-679.
71. Scott-Moncrieff JC, Treadwell NG, McCullough SM, et al. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 2001; 37(3):220-227.
72. Stokol T, Brooks MB, Erb HN, et al. D-dimer concentrations in healthy dogs with disseminated intravascular coagulation. Am J Vet Res 2000; 61(4):393-398.
73. Ziegler TR, Gatzen C, Wilmore DW. Strategies for attenuating protein-catabolic responses in the critically ill. Ann Rev Med 1994; 45:459-480.
74. Streeter EM, Zsombor-Murray E, Moore KE, et al. Intestinal permeability and absorption in dogs with traumatic injury. J Vet Intern Med 2002; 16(6):669-673.
75. Cullen JJ, Caropreso DK, Ephgrave KS. The effect of endotoxin on canine jejunal motility and transit. J Surg Res 1997; 67(1):54-57.
76. Koch T, Geiger S, Ragaller MJR. Monitoring of organ dysfunction in sepsis/systemic inflammatory response syndrome: novel strategies. J Am Soc Nephrol 2001; 12:S53-S59.
77. Wall PL, Chendrasekhar A, Timberlake GA. A simple apparatus for frequent measurement of gastrointestinal intraluminal PCO. J Vet Emerg Crit Care 1998; 8(2):109-115.
78. Manson NH, Wendel TH, Eaton LR, et al. Hemodynamics, hypoglycemia, and hepato-pancreatic pathology during the course of endotoxin shock. Adv Shock Res 1981; 6(1):107-120.
79. Ruaux CG, Atwell RB. A severity score for spontaneous acute pancreatitis. Aust Vet J 1998; 76(12):804-808.
80. Rockar RA, Drobatz KS. Development of a scoring system for the veterinary trauma patient. J Vet Emerg Crit Care 1994; 4(2):77-83.
81. King LG, Stevens MT, Ostro EN, et al. A model for prediction of survival in critically ill dogs. J Vet Emerg Crit Care 1994; 4(2):85-99.